Single treatment group to evaluate the amount of time the sensor glucose values from CGM are within target range with 12 weeks of LY900014
A Study of LY900014 in Participants with Type 2 Diabetes using Continuous Glucose Monitoring
PRONTO-Time in Range
Study Length: 12 Weeks
Target Age/Sex: over 18 years, Male and Female
Participants will receive at no cost: study product, study materials and study-specific procedures